Home › Funds › Holocene Advisors, LP › RVMD

Holocene Advisors, LP position in RVMD

REVOLUTION MEDICINES INC · Health Care

Holocene Advisors, LP reported holding 1,359,269 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$254.6M, representing 0.60% of its reported portfolio and ranking #36 among its reported holdings. Holocene Advisors, LP has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.36M sh
Reported value held$254.56M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Holocene Advisors, LP's RVMD position evolved

Holocene Advisors, LP first disclosed a stake in RVMD in Q3 2023 at 2,190,722 shares (US$60.6M). The position peaked in Q2 2026 at 1,359,269 shares, worth US$254.6M. Across 12 filings, Holocene Advisors, LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,359,269 shares valued at US$254.6M — a reduction of -1,109,375 shares quarter over quarter.. Notable position changes include a 85% trim in Q4 2024 (shares fell 19% over the following quarter), a 1066% increase in Q1 2025 (shares rose 4% over the following quarter), a 45% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.19M $60.64M New
Q4 2023 2.88M $82.66M Add
Q1 2024 2.42M $78.07M Reduce
Q2 2024 2.20M $85.52M Reduce
Q3 2024 2.15M $97.48M Reduce
Q4 2024 316.60K $13.85M Reduce
Q1 2025 3.69M $130.54M Add
Q2 2025 3.63M $133.66M Reduce
Q3 2025 3.44M $160.52M Reduce
Q4 2025 1.91M $151.97M Reduce
Q1 2026 2.47M $240.08M Add
Q2 2026 1.36M $254.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Holocene Advisors, LP held RVMD?

Holocene Advisors, LP has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Holocene Advisors, LP's current position in RVMD?

As of Q2 2026, Holocene Advisors, LP holds 1.36M shares of RVMD (REVOLUTION MEDICINES INC), valued at $254.56M, representing 0.60% of its reported portfolio and ranking #36.

Has Holocene Advisors, LP been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Holocene Advisors, LP reduced its position in RVMD. The position peaked in Q2 2026 at 1.36M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.